“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart

Article: The strategic plan for paediatric cancer treatment and clinical research development in Belgium

€2.42

SKU: product-article-10755 Category: General

Description
Reviews (0)

Description

The strategic plan for paediatric cancer treatment and clinical research development in Belgium

Reviews

There are no reviews yet.

Be the first to review “Article: The strategic plan for paediatric cancer treatment and clinical research development in Belgium”

Top

Article: The strategic plan for paediatric cancer treatment and clinical research development in Belgium

Description

Reviews

Related products

Article: Highlights in squamous cell carcinoma of the head and neck

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Highlights in urologic cancer